Joshua De Guzman

Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics

I. Nabi, David E. Williams, R. Andersen, 2022, Antiviral Research.

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants

R. Leduc, M. Paetzel, N. Strynadka, 2023, Emerging microbes & infections.